Differentiation-associated downregulation of poly(ADP-Ribose) polymerase-1 expression in myoblasts serves to increase their resistance to oxidative stress

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Oláh, Gábor ^a   Szczesny, Bartosz ^a,c   Brunyánszki, Attila ^a   Lopez García, Isabel A ^a   Gerö, Domokos ^a   Radák, Zsolt ^b   Szabo, Csaba ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF PHYSICAL EDUCATION   (Hungary)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; LACTATE DEHYDROGENASE; MYOGENIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TRANSCRIPTION FACTOR PAX7; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; GLYCOLYSIS; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOUSE; MTT ASSAY; MUSCLE FIBER MEMBRANE RESISTANCE; MUSCLE FIBRIL; MUSCLE MITOCHONDRION; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ANIMAL; APOPTOSIS; CELL CULTURE; CHEMISTRY; ENERGY METABOLISM; ENZYMOLOGY; FLUORESCENCE MICROSCOPY; METABOLISM; MITOCHONDRION; PATHOLOGY; SKELETAL MUSCLE CELL;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; ENERGY METABOLISM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; MYOBLASTS; OXIDATIVE STRESS; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; RATS;

EID: 84941712094     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134227     Document Type: Article

References (54)

1. Jagtap P, Szabo C (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4: 421-440. doi: 10.1038/nrd1718.
2. Pacher P, Szabo C (2008) Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 173: 2-13. doi: 10.2353/ajpath.2008.080019.
3. De Vos M, Schreiber V, Dantzer F (2012) The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem Pharmacol 84: 137-146. doi: 10.1016/j.bcp.2012.03. 018.
4. Curtin NJ, Szabo C (2012) Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med 34: 1217-56. doi: 10.1016/j.mam.2013.01.006.
5. Sakellariou GK, Jackson MJ, Vasilaki A (2014) Redefining the major contributors to superoxide production in contracting skeletal muscle. The role of NAD(P)H oxidases. Free Radic Res 48: 12-29. doi: 10. 3109/10715762.2013.830718.
6. Hepple RT (2014) Mitochondrial involvement and impact in aging skeletal muscle. Front Aging Neurosci 6: 211. doi: 10.3389/fnagi.2014.00211.
7. Aoi W, Naito Y, Yoshikawa T (2014) Potential role of oxidative protein modification in energy metabolism in exercise. Subcell Biochem 77: 175-87. doi: 10.1007/978-94-007-7920-4-15.
8. Nikolaidis MG, Kyparos A, Spanou C, Paschalis V, Theodorou AA, Vrabas IS (2012) Redox biology of exercise: an integrative and comparative consideration of some overlooked issues. J Exp Biol 215: 1615-25. doi: 10.1242/jeb.067470.
9. Radák Z, Naito H, Kaneko T, Tahara S, Nakamoto H, Takahashi R, et al. (2002) Exercise training decreases DNA damage and increases DNA repair and resistance against oxidative stress of proteins in aged rat skeletal muscle. Pflugers Arch 445: 273-8. doi: 10.1007/s00424-002-0918-6
10. Ji LL (2008) Modulation of skeletal muscle antioxidant defense by exercise: Role of redox signaling. Free Radic Biol Med 44: 142-52. doi: 10.1016/j.freeradbiomed.2007.02.031.
11. Radak Z, Chung HY, Goto S (2008) Systemic adaptation to oxidative challenge induced by regular exercise. Free Radic Biol Med 44: 153-9. doi: 10.1016/j.freeradbiomed.2007.01.029.
12. Radak Z, Bori Z, Koltai E, Fatouros IG, Jamurtas AZ, Douroudos II, et al. (2011) Age-dependent changes in 8-oxoguanine-DNA glycosylase activity are modulated by adaptive responses to physical exercise in human skeletal muscle. Free Radic Biol Med 51: 417-23. doi: 10.1016/j.freeradbiomed. 2011.04.018.
13. Szczesny B, Tann AW, Mitra S (2010) Age-and tissue-specific changes in mitochondrial and nuclear DNA base excision repair activity in mice: susceptibility of skeletal muscles to oxidative injury. Mech Ageing Dev 131: 330-7. doi: 10.1016/j.mad.2010.03 243
14. Wang YX, Dumont NA, Rudnicki MA (2014) Muscle stem cells at a glance. J Cell Sci 127: 4543-8. doi: 10.1242/jcs.151209.
15. Bentzinger CF, Wang YX, Dumont NA, Rudnicki MA (2013) Cellular dynamics in the muscle satellite cell niche. EMBO Rep 14: 1062-72. doi: 10.1038/embor.2013.182.
16. Hudson MB, Woodworth-Hobbs ME, Zheng B, Rahnert JA, Blount MA, Gooch JL, et al. (2014) miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosomemediated export. Am J Physiol Cell Physiol 306: C551-8. doi: 10.1152/ajpcell.00266.2013
17. Stoppelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Assoian RK (1985) Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci U S A 82: 4939-43..
18. Cohen S, Nathan JA, Goldberg AL (2015) Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 14: 58-74. doi: 10.1038/nrd4467.
19. Thibault R, Cano N, Pichard C (2011) Quantification of lean tissue losses during cancer and HIV infection/AIDS. Curr Opin Clin Nutr Metab Care 14: 261-7. doi: 10.1097/MCO.0b013e3283455d60
20. Diaz EC, Herndon DN, Porter C, Sidossis LS, Suman OE, Børsheim E (2014) Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns. Burns pii: S0305-4179(14)00346-5. doi: 10.1016/j.burns.2014.10.010.
21. Hawke T, Garry D (2001) Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91: 534-551..
22. Braun T, GautelM (2011) Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nature Rev Mol Cell Biol 12: 349-361. doi: 10.1038/nrm3118.
23. Wang YX, Rudnicki MA (2012) Satellite cells, the engines of muscle repair. Nat Rev Mol Cell Biol 13: 127-133. doi: 10.1038/nrm3265.
24. Yaffe D, Saxel O (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-7. PMID: 563524.
25. Ferri P, Barbieri E, Burattini S, Guescini M, D'Emilio A, Biagiotti L, et al. (2009) Expression and subcellular localization of myogenic regulatory factors during the differentiation of skeletal muscle C2C12 myoblasts. J Cell Biochem 108: 1302-17. doi: 10.1002/jcb.22360.
26. Shen X, Collier JM, Hlaing M, Zhang L, Delshad EH, Bristow J, et al. (2003) Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev Dyn 226: 128-138. doi: 10.1002/dvdy. 10200.
27. Olguin HC, Olwin BB (2004) Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. Dev Biol 275: 375-388. doi: 10.1016/j.ydbio.2004. 08.015.
28. Szczesny B, Olah G, Walker DK, Volpi E, Rasmussen BB, Mitra S, et al. (2013) Deficiency in Repair of the Mitochondrial Genome Sensitizes Proliferating Myoblasts to Oxidative Damage. PLoS One 8: e75201. doi: 10.1371/journal.pone.0075201.
29. Gerö D, Szoleczky P, Modis K, Pribis JP, Al-Abed Y, Yang H, et al. (2013) Identification of pharmacological modulators of HMGB1-induced inflammatory response by cell-based screening. PLoS One 8: e65994. doi: 10.1371/journal.pone.0065994.
30. Gerö D, Szoleczky P, Chatzianastasiou A, Papapetropoulos A, Szabo C (2014) Modulation of poly (ADP-ribose) polymerase-1 (PARP-1) mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes. Mol Med 20: 313-328. doi: 10.2119/molmed.2014.00102 PMID: 24842055.
31. Módis K, Gerö D, Erdélyi K, Szoleczky P, DeWitt D, Szabo C (2012) Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress. Biochem Pharmacol 83: 633-43. doi: 10.1016/j.bcp.2011.12.014. 22198485
32. Brunyanszki A, Olah G, Coletta C, Szczesny B, Szabo C (2014) Mitochondrial poly(ADP-ribose) polymerase activation by the β-adrenoceptor/cAMP/protein kinase A axis during oxidative stress. Mol Pharmacol 86: 450-62. doi: 10.1124/mol.114.094318.
33. Módis K, Panopoulos P, Coletta C, Papapetropoulos A, Szabo C (2013) Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A. Biochem Pharmacol 86: 1311-9. doi: 10. 1016/j.bcp.2013.08.064.
34. Rogers GW, Brand MD, Petrosyan S, Ashok D, Elorza AA, Ferrick DA, et al. (2011) High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS ONE 6: p. e21746. doi: 10.1371/journal.pone.0021746.
35. Frezza C, Cipolat S, Scorrano L (2007) Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat Protoc 2: 287-295. doi: 10.1038/nprot.2006.478
36. Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó E, et al. (2002) Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 30: 1071-82..
37. Chen M, Zsengellér Z, Xiao CY, Szabo C (2004) Mitochondrial-to-nuclear translocation of apoptosisinducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1. Cardiovasc Res 63: 682-8..
38. Erdélyi K, Bai P, Kovacs I, Szabo E, Mocsar G, Kakuk A, et al. (2009) Dual role of poly(ADP-ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 cells. FASEB J 23: 3553-63. doi: 10.1096/fj.09-133264.
39. Rossi MN, Carbone M, Mostocotto C, Mancone C, Tripodi M, Maione R, et al. (2009) Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J Biol Chem 284: 31616-24. doi: 10.1074/jbc.M109.025882.
40. Szczesny B, Brunyanszki A, Olah G, Mitra S, Szabo C (2014) Opposing roles of mitochondrial and nuclear PARP1 in the regulation of mitochondrial and nuclear DNA integrity: implications for the regulation of mitochondrial function. Nucleic Acids Res 42: 13161-73. doi: 10.1093/nar/gku1089
41. Zhang P, Wong C, Liu D, Finegold M, Harper JW, Elledge SJ (1999) p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev 13: 213-24..
42. Kraus WL (2008) Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Curr Opin Cell Biol 20: 294-302. doi: 10.1016/j.ceb.2008.03.006
43. Andrabi SA, Umanah GK, Chang C, Stevens DA, Karuppagounder SS, Gagné JP, et al. (2014) Poly (ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc Natl Acad Sci U S A 111: 10209-14. doi: 10.1073/pnas.1405158111.
44. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, et al. (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3: 1089-95.
45. Heller B, Wang ZQ, Wagner EF, Radons J, Bürkle A, Fehsel K, et al. (1995) Inactivation of the poly (ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 270: 11176-80..
46. Pieper AA, Walles T, Wei G, Clements EE, Verma A, Snyder SH, et al. (2000) Myocardial postischemic injury is reduced by polyADPribose polymerase-1 gene disruption. Mol Med 6: 271-82.
47. Ding Y, Zhou Y, Lai Q, Li J, Gordon V, Diaz FG (2001) Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment. Brain Res 915: 210-7..
48. Bai P, Cantó C, Oudart H, Brunyánszki A, Cen Y, Thomas C, et al. (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13: 461-8. doi: 10.1016/j.cmet.2011. 03.004.
49. Kauppinen A1, Suuronen T, Ojala J, Kaarniranta K, Salminen A (2013) Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25: 1939-48. doi: 10.1016/j.cellsig.2013.06.007.
50. Koch-Nolte F, Fischer S, Haag F, Ziegler M (2011) Compartmentation of NAD+-dependent signalling. FEBS Lett 585: 1651-6. doi: 10.1016/j.febslet.2011.03.045.
51. Dölle C, Rack JG, Ziegler M (2013) NAD+ and ADP-ribose metabolism in mitochondria. FEBS J 280: 3530-41. doi: 10.1111/febs.12304.
52. Frederick DW, Davis JG, Dávila A Jr, Agarwal B, Michan S, Puchowicz MA, et al. (2014) Increasing NAD+ synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism. J Biol Chem 290: 1546-58. doi: 10.1074/jbc.M114.579565.
53. Pirinen E, Cantó C, Jo YS, Morato L, Zhang H, Menzies KJ, et al. (2014) Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab 19: 1034-41. doi: 10.1016/j.cmet.2014.04.002.
54. Mohamed JS, Hajira A, Pardo PS, Boriek AM (2014) MicroRNA-149 inhibits PARP-2 and promotes mitochondrial biogenesis via SIRT-1/PGC-1α network in skeletal muscle. Diabetes 63: 1546-59. doi: 10.2337/db13-1364.